Rare female genital cancers
On demand lectures available from 1 December 2021
Rare female genital cancers
On demand lectures available from 1 December 2021
The online course on rare female genital cancers is addressed to an international audience of clinical oncologists interested in advancing their knowledge and skills on the clinical management of these tumors in a multidisciplinary context.
Taking into account that “networking” is the keyword to improve quality of care of rare cancers, the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing the collaboration among oncologists of different countries who are already part of the network or willing to be part of it in the near future.
LEARNING OBJECTIVES
- To provide an overview of current multidisciplinary state-of-the-art treatment of rare female genital cancers
- To establish connections for future distance clinical mentoring/tutoring/networking
PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 4 CME credits have been granted to this event.The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
CME credits will be available until 1 December 2023.
ESO COLLEGE CREDITS
The course enables ESO College members to earn College credits and therefore access more benefits. Full and active participation in the Course earns participants 4 credits.
REGISTRATION
Registration for the course is required but free (you can find the registration link on the right).
Germ cell tumours
Sex cord stromal tumours: Granulosa cell tumours/juvenile versus adult; Sertoli-Leydig cell tumours
Low grade serous tumours
Low and high risk gestational trophoblastic neoplasia
Atypical placental site nodule, placental site trophoblastic tumour, epithelioid trophoblastic tumour
Non squamous carcinoma: vulvar and vaginal
Ovarian and uterine carcinosarcomas
Small cell cancers: cervix versus ovary
Alice Bergamini
Ospedale San Raffaele, Obstetrics and Gynecology Dept, Milano, IT
Christianne Lok
Netherlands Cancer Institute, ., Amsterdam, NL
Christoph Grimm
Medical University of Vienna, Division of General Gynecology and Gynecological Oncology, Vienna, AT
Domenica Lorusso
Gemelli University Hospital, Gynecological Oncology Unit, Roma, IT
Frédéric Amant
University Hospitals of Leuven, Dept. of Gynecologic Oncology, Leuven, BE
Isabelle Ray-Coquard
Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Jalid Sehouli
Charité Medical University, Gynaecological Clinic, Berlin, DE
Michael Seckl
Imperial College London, Hammersmith Campus, London, UK
